Cibus, Inc. (CBUS) — Stock Score Summary

Cibus, Inc. (CBUS) has a MoatMap StockRank of 1/100 based on Quality (10/100), Value (35/100), and Momentum (23/100) factor scores. The current signal is STRONG SELL. Agricultural gene-editing firm with high cash burn and pre-revenue characteristics, failing our quality compounder filter.

Cibus, Inc. develops and commercializes advanced non-GMO and gene-edited plant traits for agricultural applications, focusing on improving crop yields and sustainability. The company leverages its proprietary Rapid Trait Development System (RTDS) platform, allowing precise genetic modifications without introducing foreign DNA. Cibus is a pioneer in sustainable agricultural biotechnology, offering an alternative to traditional GMOs.

Key Financial Metrics

Price$1.23
Market Cap$117M
P/E (Forward)-2.22
Price/Book3.48
Return on Equity-221.0%
Return on Invested Capital-33.6%
Debt/Equity1227.56
Gross Margin100.0%
Operating Margin-1273.3%
Revenue Growth-12.8%
Free Cash Flow$-52M

Cibus, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Cibus, Inc.’s (CBUS) StockRank?
MoatMap’s StockRank for Cibus, Inc. (CBUS) is 1/100, with a Strong Sell signal. It is a composite of Quality (10), Value (35), and Momentum (23) factor ranks across MoatMap’s 19,000+ stock universe.
Does Cibus, Inc. have an economic moat?
Cibus, Inc. (CBUS) has a Quality factor score of 10/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Cibus, Inc. a buy, hold, or sell?
MoatMap’s current signal for Cibus, Inc. (CBUS) is Strong Sell, based on a StockRank of 1/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Cibus, Inc. in?
Cibus, Inc. (CBUS) operates in the Healthcare sector, specifically the Biotechnology industry (United States).